Skip to main content

Puma Biotechnology, Inc.

PBYI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001401667

In the last 90 days, Puma Biotechnology, Inc. insiders filed 0 open-market purchases and 5 sales; 160 institutions reported holding it in 13F filings for Q2 2026, worth $313.6M in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Puma Biotechnology, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
5 filings
5 insiders, $1.12M in total
Insiders trading
5
Net value
−$1.12M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Puma Biotechnology, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Puma Biotechnology, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Wilson Troy EdwardDirector54,750Sep 16, 20262
Cesano AlessandraDirector56,700Sep 16, 20262
Auerbach Alan HPresident and CEO7,261,671Jul 8, 20263
Hunt Douglas MSee Remarks196,841Jul 8, 20263
Nougues Maximo FChief Financial Officer230,637Jul 8, 20263
Moyes Jay MDirector58,322Jun 15, 20261
Miller Michael PatrickDirector81,000Jun 15, 20262
Senderowicz AdrianDirector27,000Jun 15, 20261
Dorval AllisonDirector90,780Jun 15, 20261
Stuglik Brian MDirector113,858Jun 15, 20261
Ludwig Jeffrey JeromeChief Commercial Officer156,792Feb 11, 20250
Wong Alvin FChief Scientific Officer141,241Feb 14, 20240

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Apr 5, 2022 (view filing)Apr 41 dayHunt Douglas MSee RemarksSSale−413$3.08−$1.27K−0.5%82.3K after
Apr 5, 2022 (view filing)Apr 41 dayNougues Maximo FChief Financial OfficerSSale−206$3.08−$634.48−0.2%121.4K after
Mar 17, 2022 (view filing)Mar 161 dayMiller Michael PatrickDirectorSSale−25.7K$2.80−$71.8K−32.7%52.9K after
Mar 4, 2022 (view filing)Mar 22 daysNougues Maximo FChief Financial OfficerSSale−169$2.26−$381.94−0.3%59.4K after
Mar 4, 2022 (view filing)Mar 22 daysHunt Douglas MSee RemarksSSale−446$2.26−$1.01K−0.7%60.1K after
Mar 4, 2022 (view filing)Mar 22 daysAuerbach Alan HPresident and CEOSSale−1.29K$2.26−$2.92K0.0%4.39M after
Feb 3, 2022 (view filing)Feb 21 dayHunt Douglas MSee RemarksSSale−533$2.47−$1.32K−0.9%60.5K after
Feb 3, 2022 (view filing)Feb 21 dayNougues Maximo FChief Financial OfficerSSale−199$2.48−$493.52−0.3%59.6K after
Feb 3, 2022 (view filing)Feb 21 dayAuerbach Alan HPresident and CEOSSale−1.32K$2.46−$3.24K0.0%4.39M after
Jan 5, 2022 (view filing)Jan 32 daysLudwig Jeffrey JeromeChief Commercial OfficerSSale−4.73K$3.20−$15.1K−13.1%31.3K after
Jan 5, 2022 (view filing)Jan 32 daysHunt Douglas MSee RemarksSSale−3.71K$3.21−$11.9K−5.7%61.1K after
Jan 5, 2022 (view filing)Jan 32 daysAuerbach Alan HPresident and CEOSSale−22.9K$3.19−$73.0K−0.5%4.39M after
Jan 5, 2022 (view filing)Jan 32 daysNougues Maximo FChief Financial OfficerSSale−7.48K$3.19−$23.9K−11.1%59.8K after
Dec 6, 2021 (view filing)Dec 24 daysHunt Douglas MSee RemarksSSale−441$2.90−$1.28K−0.7%64.8K after
Dec 6, 2021 (view filing)Dec 24 daysWong Alvin FChief Scientific OfficerSSale−1.13K$2.91−$3.29K−6.2%17.2K after
Dec 6, 2021 (view filing)Dec 24 daysNougues Maximo FChief Financial OfficerSSale−162$2.95−$477.9−0.2%67.3K after
Dec 6, 2021 (view filing)Dec 24 daysAuerbach Alan HPresident and CEOSSale−1.84K$2.90−$5.33K0.0%4.41M after
Nov 3, 2021 (view filing)Nov 21 dayNougues Maximo FChief Financial OfficerSSale−156$5.67−$884.52−0.2%67.4K after
Nov 3, 2021 (view filing)Nov 21 dayHunt Douglas MSee RemarksSSale−427$5.64−$2.41K−0.7%65.2K after
Nov 3, 2021 (view filing)Nov 21 dayAuerbach Alan HPRESIDENT AND CEOSSale−1.79K$5.63−$10.1K0.0%4.41M after
Oct 6, 2021 (view filing)Oct 42 daysNougues Maximo FChief Financial OfficerSSale−161$6.20−$998.2−0.2%67.6K after
Oct 6, 2021 (view filing)Oct 42 daysHunt Douglas MSee RemarksSSale−443$6.15−$2.72K−0.7%65.7K after
Oct 6, 2021 (view filing)Oct 42 daysAuerbach Alan HPresident and CEOSSale−1.86K$6.15−$11.4K0.0%4.42M after
Sep 7, 2021 (view filing)Sep 25 daysHunt Douglas MSee RemarksSSale−422$7.52−$3.17K−0.6%66.1K after
Sep 3, 2021 (view filing)Sep 21 dayAuerbach Alan HPRESIDENT AND CEOSSale−1.76K$7.60−$13.4K0.0%4.42M after
Sep 3, 2021 (view filing)Sep 21 dayNougues Maximo FChief Financial OfficerSSale−155$7.51−$1.16K−0.2%67.8K after
Aug 3, 2021 (view filing)Aug 21 dayNougues Maximo FChief Financial OfficerSSale−154$7.54−$1.16K−0.2%67.9K after
Aug 3, 2021 (view filing)Aug 21 dayHunt Douglas MSee RemarksSSale−420$7.53−$3.16K−0.6%66.5K after
Aug 3, 2021 (view filing)Aug 21 dayAuerbach Alan HPRESIDENT AND CEOSSale−1.76K$7.53−$13.3K0.0%4.42M after
Jul 6, 2021 (view filing)Jul 24 daysAuerbach Alan HPRESIDENT AND CEOSSale−5.33K$8.84−$47.1K−0.1%4.42M after
Jul 6, 2021 (view filing)Jul 24 daysNougues Maximo FChief Financial OfficerSSale−155$9.26−$1.44K−0.2%68.1K after
Jul 6, 2021 (view filing)Jul 24 daysHunt Douglas MSee RemarksSSale−1.02K$9.15−$9.30K−1.5%66.9K after